Trent Breaks Down Mutation Testing and ctDNA Monitoring in G

Dr Trent discusses the need for improved awareness around mutation testing in GIST, the limitations of current clinical trial criteria, and the potential for ctDNA to become a longitudinal cancer monitoring tool, helping to prevent invasive means of measuring disease progression.

Related Keywords

University Of Miami , Florida , United States , Caroline Seymour , Jonathanc Trent , Deciphera Pharmaceuticals , University Of Miami Health System , Linkedin , Sylvester Comprehensive Cancer Center , Twitter , Clinical Research , Facebook , Miami Health System , Apple Podcasts , Google Podcasts , Amazon Music , D , Phd , Mutation Testing In Gist ,